Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Löschmann

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Psychopharmacology|January 1, 1986
Effects of forskolin and cyclic nucleotides in animal models predictive of antidepressant activity: interactions with rolipramH Wachtel, P A Löschmann
Journal of Neural Transmission (Vienna, Austria : 1996)|February 27, 2019
Classical dopamine agonistsR Horowski, P-A Löschmann
Neuroscience Letters|August 17, 1992
NBQX (6-nitro-sulfamoyl-benzo-quinoxaline-dione) and CPP (3-carboxy-piperazin-propyl phosphonic acid) potentiate dopamine agonist induced rotations in substantia nigra lesioned ratsH Wachtel, M Kunow, P A Löschmann
British Journal of Pharmacology|October 29, 2000
Antidystonic efficacy of nitric oxide synthase inhibitors in a rodent model of primary paroxysmal dystoniaA Richter, P A Löschmann, W Löscher
Current Opinion in Neurology|August 1, 1994
New medical and surgical treatments for Parkinson's diseaseT Klockgether, P A Löschmann, U Wüllner
European Journal of Pharmacology|November 3, 1994
The novel antiepileptic drug, lamotrigine, exerts prodystonic effects in a mutant hamster model of generalized dystoniaA Richter, P A Löschmann, W Löscher
Pharmacopsychiatry|September 1, 1988
Absence of anticholinergic activity of rolipram, an antidepressant with a novel mechanism of action, in three different animal models in vivoH Wachtel, P A Löschmann, P Pietzuch
Clinical Neuropharmacology|January 1, 1992
Bromerguride--an ergoline derivative with atypical neuroleptic propertiesP A Löschmann, R Horowski, H Wachtel
Movement Disorders : Official Journal of the Movement Disorder Society|May 29, 1999
The NMDA antagonist budipine can alleviate levodopa-induced motor fluctuationsS Spieker, P A Löschmann, T Klockgether
Journal of Neural Transmission. Supplementum|January 1, 1992
Synergism of NBQX with dopamine agonists in the 6-OHDA rat model of Parkinson's diseaseP A Löschmann, M Kunow, H Wachtel
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Psychopharmacology|January 1, 1986
Effects of forskolin and cyclic nucleotides in animal models predictive of antidepressant activity: interactions with rolipramH Wachtel, P A Löschmann
Journal of Neural Transmission (Vienna, Austria : 1996)|February 27, 2019
Classical dopamine agonistsR Horowski, P-A Löschmann
Neuroscience Letters|August 17, 1992
NBQX (6-nitro-sulfamoyl-benzo-quinoxaline-dione) and CPP (3-carboxy-piperazin-propyl phosphonic acid) potentiate dopamine agonist induced rotations in substantia nigra lesioned ratsH Wachtel, M Kunow, P A Löschmann
British Journal of Pharmacology|October 29, 2000
Antidystonic efficacy of nitric oxide synthase inhibitors in a rodent model of primary paroxysmal dystoniaA Richter, P A Löschmann, W Löscher
Current Opinion in Neurology|August 1, 1994
New medical and surgical treatments for Parkinson's diseaseT Klockgether, P A Löschmann, U Wüllner
European Journal of Pharmacology|November 3, 1994
The novel antiepileptic drug, lamotrigine, exerts prodystonic effects in a mutant hamster model of generalized dystoniaA Richter, P A Löschmann, W Löscher
Pharmacopsychiatry|September 1, 1988
Absence of anticholinergic activity of rolipram, an antidepressant with a novel mechanism of action, in three different animal models in vivoH Wachtel, P A Löschmann, P Pietzuch
Clinical Neuropharmacology|January 1, 1992
Bromerguride--an ergoline derivative with atypical neuroleptic propertiesP A Löschmann, R Horowski, H Wachtel
Movement Disorders : Official Journal of the Movement Disorder Society|May 29, 1999
The NMDA antagonist budipine can alleviate levodopa-induced motor fluctuationsS Spieker, P A Löschmann, T Klockgether
Journal of Neural Transmission. Supplementum|January 1, 1992
Synergism of NBQX with dopamine agonists in the 6-OHDA rat model of Parkinson's diseaseP A Löschmann, M Kunow, H Wachtel
Pageof 6